Phase 1 Trial of Osimertinib with Stereotactic Radiosurgery (SRS) in Patients With Brain Metastases From EGFR Positive Non-Small-Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/18 → 1/1/21

Funding

  • Case Comprehensive Cancer Center